Literature DB >> 33930356

Japanese Current Status of Curative-Intent Surgery for Malignant Pleural Mesothelioma.

Masaki Hashimoto1, Hiroyuki Yamamoto2, Shunsuke Endo3, Morihito Okada4, Hiroaki Miyata5, Seiki Hasegawa6, Masayuki Chida7.   

Abstract

BACKGROUND: Few reports about surgical outcomes in malignant pleural mesothelioma (MPM) have been based on reliable nationwide databases. Here, we analyzed the incidence, surgical outcome, and operative risk factors using Japanese nationwide database.
METHODS: Characteristics and perioperative data from 622 patients who underwent curative-intent surgery for MPM between January 2014 and December 2017 were recorded from National Clinical Database of Japan. We analyzed the incidence, surgical outcomes, and risk factors for surgical complications after 2 surgical procedures (extrapleural pneumonectomy [EPP] and pleurectomy/decortication [P/D]).
RESULTS: During 4 years, EPP was performed in 279 patients and P/D in 343. EPP was more frequently performed in institutions less experienced in MPM, while P/D was more frequently performed in institutions well experienced in MPM (P < .001), especially in high-volume centers with more than 10 cases during this period. P/D was more frequently performed, especially in high-volume centers. The morbidity rates were 45.2% in EPP and 35.9% in P/D. Heart failure and pneumonia were most frequent in EPP, while prolonged air leakage was most frequent in P/D. Thirty-day and in-hospital mortality rates were 1.1% and 3.2% (EPP) and 1.2% and 3.2% (P/D), respectively. Regression analyses revealed that higher age (>65 years) was associated with operative complications in EPP (odds ratio, 3.56 [95% confidence interval, 1.26-8.56]), whereas no risk factor was observed in P/D.
CONCLUSIONS: In Japanese nationwide annual database, P/D was more frequently performed, especially in high-volume centers. Morbidity was higher in EPP than P/D; however, the mortality rates were quite low in Japan regardless surgical procedures.
Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33930356     DOI: 10.1016/j.athoracsur.2021.04.042

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.

Authors:  Akihiko Shimomura; Masayuki Nagahashi; Hiraku Kumamaru; Kenjiro Aogi; Sota Asaga; Naoki Hayashi; Kotaro Iijima; Takayuki Kadoya; Yasuyuki Kojima; Makoto Kubo; Minoru Miyashita; Hiroaki Miyata; Naoki Niikura; Etsuyo Ogo; Kenji Tamura; Kenta Tanakura; Masayuki Yoshida; Yutaka Yamamoto; Shigeru Imoto; Hiromitsu Jinno
Journal:  Breast Cancer       Date:  2022-06-22       Impact factor: 3.307

2.  Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy.

Authors:  Riki Okita; Yuka Mimura-Kimura; Nobutaka Kawamoto; Naoki Yamamoto; Masashi Umeda; Masanori Okada; Hidetoshi Inokawa; Yusuke Mimura; Tomoyuki Murakami; Masao Nakata; Kazunori Okabe
Journal:  Cancer Immunol Immunother       Date:  2022-09-17       Impact factor: 6.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.